Therapeutic Index [terapeutický index]

topical
6
Persistent link   https://www.medvik.cz/link/D000076162
Definition

An indicator of the benefits and risks of treatment.

DUI
D000076162 MeSH Browser
CUI
M000632369
History note
2018
Public note
2018

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E01 Diagnosis 1 793
E01.789 Prognosis 9 711
E01.789.800 Treatment Outcome 21 804
E01.789.800.190 Disease-Free Survival 1 449
E01.789.800.238 Early Termination of Clinical Trials 16
E01.789.800.262 Pathologic Complete Response 7
E01.789.800.285 Progression-Free Survival 519
E01.789.800.379 Response Evaluation Criteria in Solid Tumors 42
E01.789.800.570 Sustained Virologic Response 19
E01.789.800.665 Therapeutic Index 6
E01.789.800.665.500 Therapeutic Index, Drug 6
E01.789.800.713 Treatment Expectations
E01.789.800.760 Treatment Failure 686

N Health Care
N04 Health Services Administration 1 744
N04.761 Quality of Health Care 2 494
N04.761.559 Outcome and Process Assessment, Health Care 1 870
N04.761.559.590 Outcome Assessment, Health Care 587
N04.761.559.590.800 Treatment Outcome 21 804
N04.761.559.590.800.190 Disease-Free Survival 1 449
N04.761.559.590.800.379 Early Termination of Clinical Trials 16
N04.761.559.590.800.427 Pathologic Complete Response 7
N04.761.559.590.800.474 Progression-Free Survival 519
N04.761.559.590.800.569 Response Evaluation Criteria in Solid Tumors 42
N04.761.559.590.800.665 Sustained Virologic Response 19
N04.761.559.590.800.713 Therapeutic Index 6
N04.761.559.590.800.713.500 Therapeutic Index, Drug 6
N04.761.559.590.800.737 Treatment Expectations
N04.761.559.590.800.760 Treatment Failure 686
N05 Health Care Quality, Access, and Evaluation 686
N05.715 Quality of Health Care 2 494
N05.715.360 Health Care Evaluation Mechanisms 201
N05.715.360.575 Outcome and Process Assessment, Health Care 1 870
N05.715.360.575.575 Outcome Assessment, Health Care 587
N05.715.360.575.575.800 Treatment Outcome 21 804
N05.715.360.575.575.800.190 Disease-Free Survival 1 449
N05.715.360.575.575.800.379 Early Termination of Clinical Trials 16
N05.715.360.575.575.800.427 Pathologic Complete Response 7
N05.715.360.575.575.800.474 Progression-Free Survival 519
N05.715.360.575.575.800.569 Response Evaluation Criteria in Solid Tumors 42
N05.715.360.575.575.800.665 Sustained Virologic Response 19
N05.715.360.575.575.800.713 Therapeutic Index 6
N05.715.360.575.575.800.713.500 Therapeutic Index, Drug 6
N05.715.360.575.575.800.737 Treatment Effect Heterogeneity
N05.715.360.575.575.800.749 Treatment Expectations
N05.715.360.575.575.800.760 Treatment Failure 686

Add

Narrower terms